| Patent | Date |
|---|
Treatment of Cancer
App 20220305037 - Bearss; David J. ; et al. | 2022-09-29 |
Treatment of Cancer
App 20220257581 - Bearss; David J. ; et al. | 2022-08-18 |
AXL kinase inhibitors and use of the same
Grant 11,400,091 - Siddiqui-Jain , et al. August 2, 2 | 2022-08-02 |
Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure
App 20220125776 - Bearss; David J. ; et al. | 2022-04-28 |
Nanoparticle-based Imaging And Therapy
App 20210401399 - Linder; Richard J. ; et al. | 2021-12-30 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20210261585 - Siddiqui-Jain; Adam ; et al. | 2021-08-26 |
Combination Therapies For Treatment Of Cancer
App 20210228582 - Bearss; David J. ; et al. | 2021-07-29 |
Axl Kinase Inhibitors And Use Of The Same
App 20210205304 - Siddiqui-Jain; Adam ; et al. | 2021-07-08 |
Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same
Grant 11,040,038 - Warner , et al. June 22, 2 | 2021-06-22 |
Materials And Methods For Treating Cancer
App 20210145830 - Kenderian; Saad J. ; et al. | 2021-05-20 |
Jak2 And Alk2 Inhibitors And Methods For Their Use
App 20210070715 - Mollard; Alexis ; et al. | 2021-03-11 |
Predicting Response To Alvocidib By Mitochondrial Profiling
App 20210052568 - WARNER; Steven L. ; et al. | 2021-02-25 |
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
App 20210000825 - Siddiqui-Jain; Adam ; et al. | 2021-01-07 |
Combination therapies for treatment of cancer
Grant 10,835,537 - Bearss , et al. November 17, 2 | 2020-11-17 |
Alk5 Inhibitors For Treating Myelodysplastic Syndrome
App 20200323851 - BEARSS; David J. ; et al. | 2020-10-15 |
Methods To Target Transcriptional Control At Super-enhancer Regions
App 20200316084 - WARNER; Steven L. ; et al. | 2020-10-08 |
Compositions Comprising Pkm2 Modulators And Methods Of Treatment Using The Same
App 20200297698 - WARNER; Steven L. ; et al. | 2020-09-24 |
Methods For Treating Castration-resistant And Castration-sensitive Prostate Cancer
App 20200281949 - WARNER; Steven L. ; et al. | 2020-09-10 |
Cyclin-dependent Kinase Inhibitors In Combination With Anthracyclines For Treatment Of Cancer
App 20200276174 - BEARSS; David J. ; et al. | 2020-09-03 |
Treatment Regimen For Cancers That Are Insensitive To Bcl-2 Inhibitors Using The Mcl-1 Inhibitor Alvocidib
App 20200276215 - BEARSS; David J. ; et al. | 2020-09-03 |
JAK1 and ALK2 inhibitors and methods for their use
Grant 10,752,594 - Mollard , et al. A | 2020-08-25 |
Pkm2 Activators In Combination With Reactive Oxygen Species For Treatment Of Cancer
App 20200237766 - SIDDIQUI-JAIN; Adam ; et al. | 2020-07-30 |
Combination Therapies For Treatment Of Cancer
App 20200215071 - Bearss; David J. ; et al. | 2020-07-09 |
Profiling Peptides And Methods For Sensitivity Profiling
App 20200200737 - BEARSS; David J. ; et al. | 2020-06-25 |
Combination therapies for treatment of cancer
Grant 10,682,356 - Bearss , et al. | 2020-06-16 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20200131210 - Siddiqui-Jain; Adam ; et al. | 2020-04-30 |
Predicting response to alvocidib by mitochondrial profiling
Grant 10,624,880 - Warner , et al. | 2020-04-21 |
Methods For Treating Diseases Associated With Abnormal Acvr1 Expression And Acvr1 Inhibitors For Use In The Same
App 20200085823 - Warner; Steven L. ; et al. | 2020-03-19 |
Combination therapies for treatment of cancer
Grant 10,568,887 - Bearss , et al. Feb | 2020-02-25 |
Combination Therapies For Treatment Of Cancer
App 20200054642 - Bearss; David J. ; et al. | 2020-02-20 |
Alvocidib prodrugs having increased bioavailability
Grant 10,562,925 - Siddiqui-Jain , et al. Feb | 2020-02-18 |
Cyclin-dependent Kinase Inhibitors In Combination With Anthracyclines For Treatment Of Cancer
App 20190314357 - Bearss; David J. ; et al. | 2019-10-17 |
Profiling peptides and methods for sensitivity profiling
Grant 10,422,788 - Bearss , et al. Sept | 2019-09-24 |
Predicting Response To Alvocidib By Mitochondrial Profiling
App 20190282557 - Warner; Steven L. ; et al. | 2019-09-19 |
Predicting response to alvocidib by mitochondrial profiling
Grant 10,357,488 - Warner , et al. July 23, 2 | 2019-07-23 |
Profiling Peptides And Methods For Sensitivity Profiling
App 20190178873 - BEARSS; David J. ; et al. | 2019-06-13 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20190177350 - Siddiqui-Jain; Adam ; et al. | 2019-06-13 |
Jak2 And Alk2 Inhibitors And Methods For Their Use
App 20190119221 - Mollard; Alexis ; et al. | 2019-04-25 |
Profiling peptides and methods for sensitivity profiling
Grant 10,267,787 - Bearss , et al. | 2019-04-23 |
Alvocidib prodrugs having increased bioavailability
Grant 10,259,835 - Siddiqui-Jain , et al. | 2019-04-16 |
JAK2 and ALK2 inhibitors and methods for their use
Grant 10,202,356 - Mollard , et al. Feb | 2019-02-12 |
Predicting Response To Alvocidib By Mitochondrial Profiling
App 20190030017 - Warner; Steven L. ; et al. | 2019-01-31 |
Profiling peptides and methods for sensitivity profiling
Grant 10,132,797 - Bearss , et al. November 20, 2 | 2018-11-20 |
Profiling Peptides And Methods For Sensitivity Profiling
App 20180299432 - Bearss; David J. ; et al. | 2018-10-18 |
Methods To Target Transcriptional Control At Super-enhancer Regions
App 20180280407 - Warner; Steven L. ; et al. | 2018-10-04 |
Combination Therapies For Treatment Of Cancer
App 20180256580 - Bearss; David J. ; et al. | 2018-09-13 |
Profiling Peptides And Methods For Sensitivity Profiling
App 20180172673 - Bearss; David J. ; et al. | 2018-06-21 |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors
App 20180134719 - Vankayalapati; Hariprasad ; et al. | 2018-05-17 |
Predicting response to alvocidib by mitochondrial profiling
Grant 9,901,574 - Warner , et al. February 27, 2 | 2018-02-27 |
Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
Grant 9,828,376 - Vankayalapati , et al. November 28, 2 | 2017-11-28 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20170334938 - Siddiqui-Jain; Adam ; et al. | 2017-11-23 |
Alvocidib prodrugs having increased bioavailability
Grant 9,758,539 - Siddiqui-Jain , et al. September 12, 2 | 2017-09-12 |
Substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
Grant 9,642,857 - Vankayalapati , et al. May 9, 2 | 2017-05-09 |
Substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
Grant 9,555,024 - Vankayalapati , et al. January 31, 2 | 2017-01-31 |
Alvocidib Prodrugs Having Increased Bioavailability
App 20160340376 - Siddiqui-Jain; Adam ; et al. | 2016-11-24 |
Predicting Response To Alvocidib By Mitochondrial Profiling
App 20160303101 - Warner; Steven L. ; et al. | 2016-10-20 |
Jak2 And Alk2 Inhibitors And Methods For Their Use
App 20160214944 - MOLLARD; Alexis ; et al. | 2016-07-28 |
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide Analogs As Histone Demethylase Inhibitors
App 20160120875 - Vankayalapati; Hariprasad ; et al. | 2016-05-05 |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
Grant 9,296,703 - Vankayalapati , et al. March 29, 2 | 2016-03-29 |
Substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
Grant 9,266,838 - Vankayalapati , et al. February 23, 2 | 2016-02-23 |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors
App 20160046586 - Bearss; David J. ; et al. | 2016-02-18 |
Substituted N-(3-(Pyrimidin-4-YL)Phenyl)Acrylamide Analogs as Tyrosine Receptor Kinase BTK Inhibitors
App 20150368208 - Vankayalapati; Hariprasad ; et al. | 2015-12-24 |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
Grant 9,206,176 - Bearss , et al. December 8, 2 | 2015-12-08 |
Ankle and foot bone growth compositions and methods
Grant 9,155,629 - Remington , et al. October 13, 2 | 2015-10-13 |
Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors
App 20150252048 - Vankayalapati; Hariprasad ; et al. | 2015-09-10 |
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide Analogs As Histone Demethylase Inhibitors
App 20150150864 - Vankayalapati; Hariprasad ; et al. | 2015-06-04 |
Protein kinase inhibitors
Grant 8,999,988 - Hurley , et al. April 7, 2 | 2015-04-07 |
Substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
Grant 8,987,335 - Vankayalapati , et al. March 24, 2 | 2015-03-24 |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors
App 20150018349 - Bearss; David J. ; et al. | 2015-01-15 |
Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase
Grant 8,901,120 - Bearss , et al. December 2, 2 | 2014-12-02 |
Oxo-imidazolyl compounds
Grant 8,759,384 - Bearss , et al. June 24, 2 | 2014-06-24 |
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide Analogs As Histone Demethylase Inhibitors
App 20140163017 - Vankayalapati; Hariprasad ; et al. | 2014-06-12 |
Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives and their use as protein kinase inhibitors
Grant 8,710,057 - Bearss , et al. April 29, 2 | 2014-04-29 |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
Grant 8,703,767 - Bearss , et al. April 22, 2 | 2014-04-22 |
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide Analogs As Histone Demethylase Inhibitors
App 20140094445 - Vakayalapati; Hariprasad ; et al. | 2014-04-03 |
Protein Kinase Inhibitors
App 20130302303 - Hurley; Laurence H. ; et al. | 2013-11-14 |
Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase
Grant 8,569,511 - Bearss , et al. October 29, 2 | 2013-10-29 |
Substituted tricyclic compounds as protein kinase inhibitors
Grant 8,552,018 - Hurley , et al. October 8, 2 | 2013-10-08 |
Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
Grant 8,445,502 - Bearss , et al. May 21, 2 | 2013-05-21 |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors
App 20130059847 - Bearss; David J. ; et al. | 2013-03-07 |
Substituted N-phenylpyrimidin-2-amine Analogs As Inhibitors Of The Axl Kinase
App 20120283261 - Bearss; David J. ; et al. | 2012-11-08 |
Substituted 3-(1h-benzo[d]imidazol-2-yl)-1h-indazole Analogs As Inhibitors Of The Pdk1 Kinase
App 20120277229 - Bearss; David J. ; et al. | 2012-11-01 |
Bone Growth Compositions and Methods
App 20120276204 - Remington; Benjamin J. ; et al. | 2012-11-01 |
Bone growth compositions and methods
Grant 8,088,402 - Remington , et al. January 3, 2 | 2012-01-03 |
Imidazo[1,2-b]pyridazine And Pyrazolo[1,5-a]pyrimidine Derivatives And Their Use As Protein Kinase Inhibitors
App 20110281863 - Bearss; David J. ; et al. | 2011-11-17 |
Axl Kinase Inhibitors
App 20110269772 - BEARSS; David J. ; et al. | 2011-11-03 |
Quinoline Derivatives For Modulating Dna Methylation
App 20110256092 - Phiasivongsa; Pasit ; et al. | 2011-10-20 |
Protein Kinase Inhibitors
App 20110212929 - Hurley; Laurence H. ; et al. | 2011-09-01 |
Axl kinase inhibitors
Grant 7,998,966 - Bearss , et al. August 16, 2 | 2011-08-16 |
Quinoline derivatives for modulating DNA methylation
Grant 7,939,546 - Phiasivongsa , et al. May 10, 2 | 2011-05-10 |
Pharmaceutical Formulations Comprising Salts Of A Protein Kinase Inhibitor And Methods Of Using Same
App 20110086112 - Bearss; David J. ; et al. | 2011-04-14 |
Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
Grant 7,820,684 - Bearss , et al. October 26, 2 | 2010-10-26 |
IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
App 20100227861 - Bearss; David J. ; et al. | 2010-09-09 |
Quinoline derivatives for modulating DNA methylation
Grant 7,790,746 - Phiasivongsa , et al. September 7, 2 | 2010-09-07 |
Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
Grant 7,750,007 - Bearss , et al. July 6, 2 | 2010-07-06 |
Quinoline Derivatives For Modulating Dna Methylation
App 20100129320 - Phiasivongsa; Pasit ; et al. | 2010-05-27 |
Oxo-Imidazolyl Compounds
App 20090298900 - Bearss; David J. ; et al. | 2009-12-03 |
Quinoline Derivatives For Modulating Dna Methylation
App 20090285772 - Phiasivongsa; Pasit ; et al. | 2009-11-19 |
Protein Kinase Inhibitors
App 20090143399 - Hurley; Laurence H. ; et al. | 2009-06-04 |
Quinoline Derivatives For Modulating Dna Methylation
App 20090099106 - Phiasivongsa; Pasit ; et al. | 2009-04-16 |
Protein Kinase Inhibitors
App 20090099165 - Hurley; Laurence H. ; et al. | 2009-04-16 |
Protein Kinase Inhibitors
App 20090029982 - Bearss; David J. ; et al. | 2009-01-29 |
Axl Kinase Inhibitors
App 20080293733 - Bearss; David J. ; et al. | 2008-11-27 |
IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
App 20080261988 - Bearss; David J. ; et al. | 2008-10-23 |
Pharmaceutical Formulations Comprising Salts Of A Protein Kinase Inhibitor And Methods Of Using Same
App 20080226747 - Bearss; David J. ; et al. | 2008-09-18 |
Pyrimidine-2,4-diamine Derivatives And Their Use As Jak2 Kinase Inhibitors
App 20080214558 - Vankayalapati; Hariprasad ; et al. | 2008-09-04 |
Protein Kinase Inhibitors
App 20080207632 - Bearss; David J. ; et al. | 2008-08-28 |
Quinoline Derivatives For Modulating Dna Methylation
App 20080175814 - Phiasivongsa; Pasit ; et al. | 2008-07-24 |
Protein Kinase Inhibitors
App 20080051414 - Hurley; Laurence H. ; et al. | 2008-02-28 |
Substituted tricyclic compounds as protein kinase inhibitors
Grant 7,335,662 - Hurley , et al. February 26, 2 | 2008-02-26 |
Substituted tricyclic compound as protein kinase inhibitors
Grant 7,326,713 - Hurley , et al. February 5, 2 | 2008-02-05 |
Substituted tricyclic compounds as protein kinase inhibitors
Grant 7,326,712 - Hurley , et al. February 5, 2 | 2008-02-05 |
Substituted tricyclic compounds as protein kinase inhibitors
Grant 7,312,226 - Hurley , et al. December 25, 2 | 2007-12-25 |
Inhibitors of polo-like kinase-1
App 20060264439 - Bearss; David J. ; et al. | 2006-11-23 |
Bone Growth Compositions and Methods
App 20060233853 - Remington; Benjamin J. ; et al. | 2006-10-19 |
Bone growth compositions and methods
Grant 7,108,862 - Remington , et al. September 19, 2 | 2006-09-19 |
Spinal fusion using an HMG-CoA reductase inhibitor
Grant 7,041,309 - Remington , et al. May 9, 2 | 2006-05-09 |
Protein kinase inhibitors
App 20050277658 - Hurley, Laurence H. ; et al. | 2005-12-15 |
Protein kinase inhibitors
App 20050239793 - Hurley, Laurence H. ; et al. | 2005-10-27 |
Protein kinase inhibitors
App 20050239794 - Hurley, Laurence H. ; et al. | 2005-10-27 |
Protein kinase inhibitors
App 20050227992 - Hurley, Laurence H. ; et al. | 2005-10-13 |
Methods for targeting quadruplex DNA
App 20040005601 - Siddiqui-Jain, Adam ; et al. | 2004-01-08 |
Bone growth compositions and methods
App 20040006125 - Remington, Benjamin J. ; et al. | 2004-01-08 |
Apparatus and methods for detecting cerebrospinal fluid
App 20040002168 - Remington, Benjamin J. ; et al. | 2004-01-01 |
Spinal fusion using an HMG-CoA reductase inhibitor
App 20030232065 - Remington, Benjamin J. ; et al. | 2003-12-18 |
| 